![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 33, 30923-30933, August 17, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
¶,
,
,
,
, and
**
From the The human mucin gene
MUC4 encodes a large transmembrane mucin that is thought to
play important roles in tumor cell biology and that is overexpressed in
human pancreatic carcinomas. In this report, we describe the structure
and functional activity of the 5'-flanking region, including 1.0 kilobase of the promoter. The long 5'-untranslated region (2.7 kilobases) is characterized by a high content of GC in its 3'-end. The
first TATA box was located at
Unité INSERM 377, Place de Verdun,
59045 Lille Cedex, France and the ¶ Laboratoires d'Endocrinologie
et
de Biochimie et de Biologie Moléculaire de
l'Hôpital C. Huriez, CHRU, 59037 Lille Cedex, France
2672/
2668. Multiple transcription
start sites and a high density of putative binding sites for Sp1
(GC and CACCC boxes), AP-1/-2/-4, cAMP-responsive element-binding
protein, GATA, GR, and STAT transcription factors were found
within the 5'-flanking region. Transcriptional activity of the
promoter was assessed using pGL3-luciferase deletion mutants in two
MUC4-expressing (CAPAN-1 and CAPAN-2) and one nonexpressing
(PANC-1) pancreatic cancer cell line. Two highly active fragments
(
219/
1 and
2781/
2572) that drive MUC4 transcription
in CAPAN-1 and CAPAN-2 cells were identified. Gel retardation assays
indicated that Sp1 and Sp3 bind to cognate cis-elements
found in the 5'-flanking region and that Sp1 transactivates, whereas
Sp3 inhibits the GC-rich region (
464/
1) in CAPAN-2 cells.
Activation of protein kinase C with phorbol ester and treatment of
cells with epidermal growth factor and transforming growth factor-
resulted in up-regulation of the promoter. Tumor necrosis factor-
and interferon (IFN)-
inflammatory cytokines had no or mild effect
on MUC4 transcriptional activity when used alone. However,
a very strong synergistic effect (10-12-fold activation) between
IFN-
and tumor necrosis factor-
or IFN-
and transforming
growth factor-
was obtained in CAPAN-2 cells. Altogether
these results demonstrate that the 5'-flanking region of
MUC4 contains epithelial cell-specific, positive, and
negative regulatory cis-elements, that Sp1/Sp3 are
important regulators of MUC4 basal expression, and that its
regulation in pancreatic cancer cells involves complex interplay
between several signaling pathways.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF241535.
§ Recipient of a CHRU de Lille-Région Nord-Pas de Calais Ph.D. fellowship. ** To whom correspondence should be addressed: Unité INSERM 377, Place de Verdun, 59045 Lille Cedex, France. Tel.: 33-320-29-88-64; Fax: 33-320-53-85-62; E-mail: vanseuni@lille.inserm.fr.This article has been cited by other articles:
![]() |
P. Chaturvedi, A. P. Singh, and S. K. Batra Structure, evolution, and biology of the MUC4 mucin FASEB J, April 1, 2008; 22(4): 966 - 981. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Fauquette, S. Aubert, S. Groux-Degroote, B. Hemon, N. Porchet, I. Van Seuningen, and P. Pigny Transcription factor AP-2{alpha} represses both the mucin MUC4 expression and pancreatic cancer cell proliferation Carcinogenesis, November 1, 2007; 28(11): 2305 - 2312. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jonckheere, A. Vincent, M. Perrais, M.-P. Ducourouble, A. K.-v. Male, J.-P. Aubert, P. Pigny, K. L. Carraway, J.-N. Freund, I. B. Renes, et al. The Human Mucin MUC4 Is Transcriptionally Regulated by Caudal-related Homeobox, Hepatocyte Nuclear Factors, Forkhead Box A, and GATA Endodermal Transcription Factors in Epithelial Cancer Cells J. Biol. Chem., August 3, 2007; 282(31): 22638 - 22650. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Homsi, R. Ducroc, J. Claustre, G. Jourdan, A. Gertler, M. Estienne, A. Bado, J.-Y. Scoazec, and P. Plaisancie Leptin modulates the expression of secreted and membrane-associated mucins in colonic epithelial cells by targeting PKC, PI3K, and MAPK pathways Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G365 - G373. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Voynow, S. J. Gendler, and M. C. Rose Regulation of Mucin Genes in Chronic Inflammatory Airway Diseases Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 661 - 665. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kamio, I. Matsushita, M. Hijikata, Y. Kobashi, G. Tanaka, K. Nakata, T. Ishida, K. Tokunaga, Y. Taguchi, S. Homma, et al. Promoter Analysis and Aberrant Expression of the MUC5B Gene in Diffuse Panbronchiolitis Am. J. Respir. Crit. Care Med., May 1, 2005; 171(9): 949 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gensch, M. Gallup, A. Sucher, D. Li, A. Gebremichael, H. Lemjabbar, A. Mengistab, V. Dasari, J. Hotchkiss, J. Harkema, et al. Tobacco Smoke Control of Mucin Production in Lung Cells Requires Oxygen Radicals AP-1 and JNK J. Biol. Chem., September 10, 2004; 279(37): 39085 - 39093. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Perez, R. Barco, I. Fernandez, S. A. Price-Schiavi, and K. L. Carraway PEA3 Transactivates the Muc4/Sialomucin Complex Promoter in Mammary Epithelial and Tumor Cells J. Biol. Chem., September 19, 2003; 278(38): 36942 - 36952. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Fischer, J. G. Cuellar, M. L. Diehl, A. M. deFreytas, J. Zhang, K. L. Carraway, and J. A. Voynow Neutrophil elastase increases MUC4 expression in normal human bronchial epithelial cells Am J Physiol Lung Cell Mol Physiol, April 1, 2003; 284(4): L671 - L679. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-D. Kim, E.-J. Kwon, D.-W. Park, S.-Y. Song, S.-K. Yoon, and S.-H. Baek Interleukin-1beta Induces MUC2 and MUC5AC Synthesis through Cyclooxygenase-2 in NCI-H292 Cells Mol. Pharmacol., November 1, 2002; 62(5): 1112 - 1118. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bazan, M. Migliavacca, I. Zanna, C. Tubiolo, N. Grassi, M. A. Latteri, M. La Farina, I. Albanese, G. Dardanoni, S. Salerno, et al. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype Ann. Onc., September 1, 2002; 13(9): 1438 - 1446. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |